Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
RecruitingNCT06795451Phase: PHASE1, PHASE2Started 2025-02-25
Summary
Spinal interoceptive pathways (SIPs) convey bodily signals to an interoceptive system in the brain and their dysregulation is linked to major depressive disorder (MDD). Current treatments are partiall
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
60 Years
Locations
Lindner Center of HopeMason, Ohio, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06795451